Hosenkoside C exhibits significant anti-inflammatory activity, making it a candidate for development in treatments targeting chronic inflammatory diseases. It has been studied for its ability to inhibit key pro-inflammatory cytokines such as TNF-α and IL-6 in cellular models. Additionally, it shows moderate antioxidant properties, which may contribute to its overall protective effects in oxidative stress-related conditions. Research also suggests potential neuroprotective applications due to its ability to cross the blood-brain barrier and reduce neuroinflammation in preclinical models. Its natural origin and low cytotoxicity profile support further exploration for use in nutraceuticals and dermatological formulations aimed at soothing skin irritation and aging.